Notably, TNF-R2, eotaxin, and MCP-3, which have previously been reported to have diagnostic utility in discriminating between VS patients and controls [27], showed a significant correlation between their tumor-secreted and plasma levels, underscoring their potential as biomarkers of VS. This evidence concerns the gene CCL11 and neoplasm.